Stay updated with breaking news from Abt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stratos Wealth Advisors LLC lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 38,287 shares of the healthcare product maker’s stock after selling 1,021 shares during the period. […]
KRS Capital Management LLC lowered its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,122 shares of the healthcare product maker’s stock after selling 462 shares during the quarter. Abbott Laboratories comprises 0.9% of […]
First Bancorp Inc ME trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 34.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 4,699 shares of the healthcare product maker’s stock after selling 2,494 shares during the quarter. First Bancorp Inc ME’s holdings in Abbott Laboratories were worth $517,000 at the end of […]
Abbott Laboratories (NYSE:ABT – Free Report) had its price objective lifted by Citigroup from $126.00 to $128.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have a buy rating on the healthcare product maker’s stock. A number of other research analysts also recently issued reports on ABT. Wells Fargo & […]
Arcblock (ABT) traded up 11.6% against the dollar during the one day period ending at 8:00 AM Eastern on April 4th. Arcblock has a market cap of $199.64 million and approximately $13.32 million worth of Arcblock was traded on exchanges in the last 24 hours. One Arcblock token can currently be bought for approximately $2.03 […]